PCB unveils pink colour kit as Pakistan vs South Africa T20 set to take place


PCB unveils pink colour kit as Pakistan vs South Africa T20 set to take place

LAHORE: Domestic cricketing body (PCB) revealed a special pink-themed kit for the first national team match as Pakistan versus South Africa match (T20 series) set to take place on Tuesday.

According to the PCB, the pink colour kit will mark all national players, who are participating in the Pakistan vs South Africa T20 first match, as equally participating in the breast cancer awareness move.

Umpires, officials and commentators of the tournament will also show their support for the campaign by wearing pink ribbons, said the Pakistan Cricket Board.

The PCB initiative doesn’t stop here as it went on to include that the stumps used in the match will also feature pink branding, adding that an awareness message will be shown on the screen as well as around the ground.

The board takes pride in using cricket’s popularity to promote social awareness, Sameer Ahmed Syed, who is PCB Chief Executive Officer, said. He also added, “Timely diagnosis of the disease can save countless lives.”

Notably, the first Pakistan versus South Africa T20I match will take place on October 28 in Rawalpindi. However, the second and third T20s will be played in Lahore on October 31 and November 1, respectively, according to the PCB notification.

The PCB has said that the three-match ODI series between the Greens and the Proteas will take place in Faisalabad from November 4 to 8.

Additionally, a new treatment nearly halves the risk of disease progression or death from a less common form of breast cancer that hasn’t seen major drug advances in over a decade, researchers cited by AFP reported in July.

Results from the study, presented at the annual meeting of the American Society for Clinical Oncology, are expected to be submitted to regulators and could soon establish a new first-line therapy for people with HER2-positive metastatic breast cancer — the advanced stage of a form that comprises 15–20 percent of all breast cancer cases, according to AFP.

HER2-positive cancers are fueled by an overactive HER2 gene, which makes too much of a protein called human epidermal growth factor receptor 2 that helps cancer cells grow and spread.

You May Also Like